Concepedia

Rinaldo Puga-Gómez

RP

4

Publications

100

Citations

4

H-Index

2014

Active since

Affiliations

Center of Molecular Immunology (Cuba)(Current)

Finlay Institute

Cuban Neuroscience Center

Sichuan University

Instituto de Hematología e Inmunología

Rinaldo Puga-Gómez is an author at Center of Molecular Immunology (Cuba) specializing in vaccinology, vaccine safety, and vaccination.

ORCID

Top concepts

Publications per year

2014–2022

4

Publications

4

A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial

Arturo Chang Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruíz et al. · The Lancet Regional Health - Americas · 2021 · 40 citations · Full text

Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: A randomized phase I clinical trial

Carlos P. Dotres, Rinaldo Puga-Gómez, Yariset Ricardo et al. · Vaccine · 2014 · 28 citations

, , +10

Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children

Rinaldo Puga-Gómez, Yariset Ricardo-Delgado, Chaumey Rojas-Iriarte et al. · International Journal of Infectious Diseases · 2022 · 21 citations · Full text

A single dose of SARS-CoV-2 FINLAY-FR-1A dimeric-RBD recombinant vaccine enhances neutralization response in COVID-19 convalescents, with excellent safety profile. A preliminary report of an open-label phase 1 clinical trial

Arturo Chang Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruíz et al. · 2021 · 11 citations · Full text

, , +14

Rows per page

1–4 of 4